Method, compositions, and kits for the treatment of medical conditions
Номер патента: NZ568694A
Опубликовано: 30-09-2011
Автор(ы): Benjamin A Auspitz, Daniels S Grau, Edward Roydon Jost-Price, M James Nichols, Todd W Chappell
Принадлежит: Zalicus Inc
Опубликовано: 30-09-2011
Автор(ы): Benjamin A Auspitz, Daniels S Grau, Edward Roydon Jost-Price, M James Nichols, Todd W Chappell
Принадлежит: Zalicus Inc
Реферат: Disclosed is a use of prednisolone or prednisolone acetate and cyclosporine A in the manufacture of a medicament for the treatment of an ophthalmic disorder in a patient, wherein said prednisolone or prednisolone acetate is formulated at a concentration between 0.05% and 0.12% and said cyclosporine A is formulated at a concentration between 0.001% and 0.049% and wherein said composition is suitable for ophthalmic administration. Also described are methods, compositions, and kits for treating an immunoinflammatory disorder, an ophthalmic disorder, a musculoskeletal disorder or pain associated therewith, a periodontal disease, or a disease or condition associated with an increased serum CRP level.
Compositions and methods for targeting gpcr for the prevention and treatment of pain
Номер патента: WO2023069682A1. Автор: Ru-Rong Ji,Sangsu BANG,Sharat Chandra. Владелец: Duke University. Дата публикации: 2023-04-27.